Los Angeles, CA, United States of America

Cindy D Ren

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Cindy D. Ren: Pioneering Biocompatible Solutions

Introduction: Cindy D. Ren, an accomplished inventor based in Los Angeles, CA, has made significant contributions to the field of biomedical engineering. With a keen focus on developing innovative materials, her work aims to foster optimal biological responses when implanted in mammals. Her groundbreaking patent underscores her commitment to advancing medical technologies.

Latest Patents: Cindy holds a notable patent titled "Biocompatible Structures and Compositions." This patent describes unique material compositions that feature various textures designed to encourage an optimal biological response upon implantation. This invention exemplifies her dedication to improving patient outcomes and enhancing the compatibility of medical devices with biological tissues.

Career Highlights: Cindy is associated with Allergan, Inc., a prominent company specializing in medical aesthetics and eye care. Her work at Allergan reflects her deep involvement in research and development aimed at introducing innovative solutions in the healthcare sector. Her insightful contributions to the field have established her as a notable figure in biomedical innovation.

Collaborations: Throughout her career, Cindy has collaborated with talented individuals such as Dennis E. Van Epps and Alexei Goraltchouk. These collaborations have not only enriched her work but also facilitated the exchange of ideas and expertise, further promoting innovation in their respective areas of research.

Conclusion: Cindy D. Ren's journey as an inventor highlights the vital role of innovation in healthcare and medical technology. With her patent for biocompatible structures, she is paving the way for future advancements that promise to improve patient care and therapeutic applications. As she continues her work at Allergan, her contributions will undoubtedly lead to further breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…